Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 3 Years in the Phase 3 POETYK PSO-1 and PSO-2 Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s241, 2023. DOI: 10.25251/skin.7.supp.241. Disponível em: https://skin.dermsquared.com/skin/article/view/2360. Acesso em: 3 nov. 2025.